Brief: Nymox Updates Regulatory Submissions For Fexapotide Treatment For Prostate Enlargement
19/06/2020 14:33
June 19 (Reuters) - Nymox Pharmaceutical Corp NYMX.O :
* NYMOX ANNOUNCES UPDATES IN REGULATORY SUBMISSIONS FOR
FEXAPOTIDE
TREATMENT FOR PROSTATE ENLARGEMENT
* NYMOX PHARMACEUTICAL - CERTAIN TASKS HAVE BEEN HAMPERED BY
COVID
PANDEMIC RESTRICTIONS
* NYMOX PHARMACEUTICAL - NOW EXPECTING TO FILE APPLICATIONS
WITH
AUTHORITIES ABOUT BY END OF Q3 OR EARLY Q4
Source text for Eikon: ID:nGNX89gBKD
Further company coverage: NYMX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nymox Pharmaceutical
See all newsBrief: Nymox Says Required To Resubmit Application To DKMA
Brief: Nymox Pharmaceutical Corp Says Terminated Employment Of Christopher R Riley As CFO (June 27)
Brief: Nymox Announces Appointment Of Christopher R. Riley As Chief Financial Officer
Brief: Nymox Appeals Deficiency Letter
U.S. STOCKS ON THE MOVE-Pot stocks, Nymox, Zynerba